4//SEC Filing
Blackman Samuel C. 4
Accession 0001415889-24-026434
CIK 0001845337other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:15 PM ET
Size
6.6 KB
Accession
0001415889-24-026434
Insider Transaction Report
Form 4
Blackman Samuel C.
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-11-07$16.03/sh−11,245$180,287→ 1,085,790 total
Holdings
- 1,000,000(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 10, 2023.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The Reporting Person is the sole manager, and has shared voting and dispositive power with his wife as members. The Reporting Person continues to report beneficial ownership of all of the Issuer's Common Stock held by the 2021 Blackman Family LLC but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein.
Documents
Issuer
Day One Biopharmaceuticals, Inc.
CIK 0001845337
Entity typeother
Related Parties
1- filerCIK 0001863676
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:15 PM ET
- Size
- 6.6 KB